Prognostic gene expression profiling in melanoma: necessary steps to incorporate into clinical practice

Prognostic gene expression profiling (GEP) tests for cutaneous melanoma (CM) are not recommended in current guidelines outside of a clinical trial. However, their use is becoming more prevalent and some practitioners are using GEP tests to guide patient management. Thus, there is an urgent need to b...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Melanoma Manag
Hauptverfasser: Grossman, Douglas, Kim, Caroline C, Hartman, Rebecca I, Berry, Elizabeth, Nelson, Kelly C, Okwundu, Nwanneka, Curiel-Lewandrowski, Clara, Leachman, Sancy A, Swetter, Susan M
Format: Artigo
Sprache:Inglês
Veröffentlicht: Future Medicine Ltd 2019
Schlagworte:
Perspective
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6920745/
https://ncbi.nlm.nih.gov/pubmed/31871621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/mmt-2019-0016
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge